Histopathology as a key to identify Sezary syndrome in patient with clinical erythroderma

  • Sonia Diovani Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Irianiwati Departement of Pathology Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Sri Awalia Febriana Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Fajar Waskito Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Dwinanda Almira Rizkiani Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Raden Roro Rini Andayani Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
  • Ani Rifko Departement of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
Keywords: malignancy, cutaneous T-cell lymphoma, Sezary syndrome, epidermotropism

Abstract

Sezary syndrome (SS) is a rare and aggressive variant of cutaneous T-cell lymphoma (CTCL), characterized by clonal proliferation of malignant T lymphocytes with skin erythroderma. The incidence of CTCL in the United States from 2000 to 2010 reached 10 cases per million people per year, accounts for only 3% of all cases of cutaneous lymphoma. In Indonesia, lymphoma ranks sixth in terms of malignancies, alongside Hodgkin lymphoma and leukemia. We reported a case of 56 y.o. woman presented with blistering lesions that turned into wounds all over her body. Skin biopsy examination revealed characteristic histopathological features, including basket weave-type orthokeratosis, focal parakeratosis, focal acanthosis, and epidermotropism of atypical lymphoid cells with cerebriform nuclei (Sezary cells). Immunohistochemical examination using CD3, CD4, and CD8 showed positive staining in the membrane and cytoplasm of tumor cells within  the dermis and epidermis. Sezary syndrome is characterized by clonal expansion of T-helper memory cells in the skin. Histopathology and immunohistochemistry could not differentiate SS from mycosis fungoides. However, histopathological examination could distinguish SS from other differential diagnoses. The diagnosis of SS can be established based on the triad of 1) generalized exfoliative dermatitis involving more than 80% of the body surface area, 2) lymphadenopathy, and 3) the presence of 5% or more malignant T-cells with cerebriform nuclei (Sezary or Lutzner cells) in peripheral blood lymphocytes. In conclusion, we present a case of SS, diagnosed based on the patient's history, physical examination, peripheral blood examination, histopathology, and immunohistochemistry.

References

Bagot M, Stadler R. Cutaneous Lymphoma. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. editors. Fitzpatrick’s Dermatology, 9ed. New York, NY: McGraw-Hill Education; 2019.

Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges 2021; 19(9):1307-34.

https://doi.org/10.1111/ddg.14610

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: A European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol 2015; 173(1):93-105.

https://doi.org/10.1111/bjd.13832

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20):2375-90.

https://doi.org/10.1182/blood-2016-01-643569

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 2017; 77:57-74.

https://doi.org/10.1016/j.ejca.2017.02.027

Miyashiro D, Torrealba MP, Manfrere KC, Pereira J, Sato MN, Sanches JA. Double-positive CD4 and CD8 Sézary syndrome. JAAD Case Rep 2017; 3(6):485-8.

https://doi.org/10.1016/j.jdcr.2017.06.036

Nagler AR, Samimi S, Schaffer A, Vittorio CC, Kim EJ, Rook AH. Peripheral blood findings in erythrodermic patients: Importance for the differential diagnosis of Sézary syndrome. J Am Acad Dermatol 2012; 66(3):503-8.

https://doi.org/10.1016/j.jaad.2011.06.014

Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management. Am J Hematol 2019; 94(9):1027-41.

https://doi.org/10.1002/ajh.25577

Foss FM, Girardi M. Mycosis fungoides and Sezary syndrome. Hematol Oncol Clin North Am 2017; 31(2):297-315.

https://doi.org/10.1016/j.hoc.2016.11.008

Punuru TR, Subashchandrabose P, Srinivasan C. Sezary syndrome- A case report. International Archives of Integrated Medicine 2017; 4(10): 262-5.

Larocca C, Kupper T. Mycosis fungoides and Sézary syndrome: An update. Hematol Oncol Clin North Am 2019; 33(1):103-20.

https://doi.org/10.1016/j.hoc.2018.09.001

Kamijo H, Miyagaki T, Norimatsu Y, Shishido‐Takahashi N, Kuzumi A, Asano Y, et al. Sézary syndrome without erythroderma: A case report and review of published work. J Dermatol 2019; 46(1):61-4.

https://doi.org/10.1111/1346-8138.14692

Lynoora ER, Rahmadewi R. Sezary syndrome mimicking generalized psoriasis vulgaris. Indonesian Journal of Tropical and Infectious Disease 2016; 6(3):59.

https://doi.org/10.20473/ijtid.v6i3.3134

Published
2025-08-13
How to Cite
1.
Diovani S, Irianiwati, Febriana SA, Waskito F, Rizkiani DA, Andayani RRR, Rifko A. Histopathology as a key to identify Sezary syndrome in patient with clinical erythroderma. InaJBCS [Internet]. 2025Aug.13 [cited 2025Aug.25];57(3). Available from: https://journal.ugm.ac.id/v3/InaJBCS/article/view/17293
Section
Articles